United States · FDA National Drug Code directory
CETIRIZINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55681-073_4e69476d-dee2-dac7-e063-6294a90a06d4
- Product NDC
- 55681-073
- Form
- TABLET
- Composition / generic term
- CETIRIZINE HYDROCHLORIDE
- Labeler
- TWIN MED, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220302
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 300 TABLET in 1 BOTTLE (55681-073-03) · 55681-073-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →